Mucosal Dose Constraints for Endoluminal High Dose Rate Brachytherapy for Esophageal Cancer

被引：0
|
作者：
Thawani, N. [1 ]
Morrow, A. [2 ]
Patel, S. [3 ]
Srivastava, S. P. [4 ]
Pinnaduwage, D. [5 ]
Jani, S. [3 ]
Sorensen, S. P. [3 ]
Ellefson, S. T. [6 ]
Mutyala, S. [7 ]
机构：
[1] UACC, CUSOM, Dign Hlth Canc Inst, Phoenix, AZ USA
[2] Creighton Sch Med, Phoenix, AZ USA
[3] Univ Arizona, Canc Ctr, Dign Hlth St Joseph Hosp, Phoenix, AZ USA
[4] Dign Hlth Canc Inst, Phoenix, AZ USA
[5] Dign Hlth, Phoenix, AZ USA
[6] St Joseph Hosp & Med Ctr, Dign Hlth Canc Inst, Phoenix, AZ USA
[7] Univ Arizona, Coll Med, Phoenix, AZ USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2024年 / 118卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2009
引用
收藏
页码：E12 / E13
页数：2
相关论文
共 50 条
  • [1] ENDOLUMINAL HIGH DOSE RATE BRACHYTHERAPY FOR ESOPHAGEAL CANCER: A FIFTEEN YEARS EXPERIENCE
    Grassini, M.
    Verna, C.
    Battaglia, E.
    Giacobbe, U.
    Niola, P.
    Nassisi, D.
    Tessa, M.
    DIGESTIVE AND LIVER DISEASE, 2011, 43 : S238 - S238
  • [2] High dose-rate endoluminal brachytherapy for primary and recurrent esophageal cancer
    Nicolay, Nils H.
    Rademacher, Johanna
    Oelmann-Avendano, Jan
    Debus, Juergen
    Huber, Peter E.
    Lindel, Katja
    STRAHLENTHERAPIE UND ONKOLOGIE, 2016, 192 (07) : 458 - 466
  • [3] Endoluminal high-dose-rate brachytherapy for locally recurrent or persistent esophageal cancer
    Taggar, Amandeep S.
    Pitter, Kenneth L.
    Cohen, Gil'ad N.
    Schattner, Mark
    Gerdes, Hans
    Markowitz, Arnold J.
    Ilson, David
    Brady, Paul
    Cuaron, John J.
    Goodman, Karyn A.
    Wu, Abraham J.
    BRACHYTHERAPY, 2018, 17 (03) : 621 - 627
  • [4] High dose-rate endoluminal brachytherapy as a treatment of primary and recurrent esophageal cancer
    Nicolay, N. H.
    Wagner, J.
    Oelmann-Avendano, J.
    Debus, J.
    Huber, P. E.
    Lindel, K.
    RADIOTHERAPY AND ONCOLOGY, 2016, 119 : S952 - S953
  • [5] Endoluminal high-dose-rate brachytherapy for early stage and recurrent esophageal cancer in medically inoperable patients
    Folkert, Michael R.
    Cohen, Gil'ad N.
    Wu, Abraham J.
    Gerdes, Hans
    Schattner, Mark A.
    Markowitz, Arnold J.
    Ludwig, Emmy
    Ilson, David H.
    Bains, Manjit S.
    Zelefsky, Michael J.
    Goodman, Karyn A.
    BRACHYTHERAPY, 2013, 12 (05) : 463 - 470
  • [6] Endoluminal high-dose-rate brachytherapy with a palliative aim in esophageal cancer: Preliminary results at the Institut Gustave Roussy
    Rovirosa, A
    Marsiglia, H
    Lartigau, E
    Zimmermann, P
    Chirat, E
    Delapierre, M
    Briot, E
    Gerbaulet, A
    TUMORI, 1995, 81 (05) : 359 - 363
  • [7] SALVAGE HIGH-DOSE-RATE BRACHYTHERAPY FOR RECURRENT ESOPHAGEAL CANCER
    Kam, S. Wong Hee
    Quero, L.
    Rivera, S.
    Michaud, S.
    Maylin, C.
    Hennequin, C.
    RADIOTHERAPY AND ONCOLOGY, 2011, 99 : S369 - S369
  • [8] HIGH-DOSE-RATE INTRALUMINAL BRACHYTHERAPY (HDRIBT) FOR ESOPHAGEAL CANCER
    HISHIKAWA, Y
    KURISU, K
    TANIGUCHI, M
    KAMIKONYA, N
    MIURA, T
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1991, 21 (05): : 1133 - 1135
  • [9] RADIATION DOSE TO ORGANS AT RISK AFTER HIGH DOSE RATE BRACHYTHERAPY FOR ESOPHAGEAL CANCER PATIENTS
    Darvish-Molla, Sahar
    Timotin, Emilia
    Skoczny, Jack
    Farrell, Thomas
    Sur, Ranjan K.
    RADIOTHERAPY AND ONCOLOGY, 2020, 150 : S41 - S41
  • [10] Treatment planning for high dose rate brachytherapy of cervical cancer based on total dose constraints
    Bahadur, Yasir A.
    Constantinescu, Camelia T.
    Hassouna, Ashraf H.
    El-Sayed, Mohamed E.
    SAUDI MEDICAL JOURNAL, 2011, 32 (05) : 495 - 503
12345